Automated analyzers and documented competency
15 min
Skills you'll build4 skills
- Choose the next CBC check from flags, red cell indices, lipemia, or cold agglutination
- Match a coagulation measurement principle to its likely interference
- Recognize when an automated identification or susceptibility result needs confirmation
- Tell course attendance from documented competency assessment
At the bench: Resolve analyzer flags before releasing a blood count · Review coagulation results and identify the next laboratory check · Reconcile organism identification with specimen source and observed growth
Try first
Get the idea
Analyzer flags and index patterns
A hematology analyzer combines impedance, light scatter, fluorescence and absorbance, and its flag rules detect selected patterns only. Some artifacts produce no flag and appear as indices that are inconsistent with each other.1
- Cold agglutination: clumped red cells pass the aperture together and count as one large event. The RBC count falls, and the MCV and the calculated MCHC rise.
- Lipemia or a very high white cell count: turbidity adds to the photometric hemoglobin, raising the hemoglobin, MCH and MCHC.1
The laboratory's procedure gives the corrective action for each pattern, such as warming the specimen, dilution, an alternate method, a manual count or a film review. A rerun without that corrective action repeats the artifact.1
Each coagulation principle has its own interference
Each detection principle measures its own signal, so each has its own interferences.2
| Detection principle | Signal | Main interference |
|---|---|---|
| Photo-optical clot detection | Light change as fibrin forms | Hemolysis, icterus, lipemia, turbidity |
| Mechanical clot detection | Movement of a ball or probe as the clot forms | Very weak clots, vibration |
| Chromogenic | Color released from a cleaved substrate | Endogenous color, other enzyme inhibitors |
A heparin-calibrated chromogenic anti-Xa assay measures all factor Xa inhibition. Residual apixaban or rivaroxaban during a switch to heparin gives a falsely high heparin result.3
Automated identification needs a pure isolate
MALDI-TOF mass spectrometry matches the spectrum of the colony it receives against its reference library. A mixed colony, a poor preparation or an organism missing from the library can return a wrong identification with a high score. A Gram stain or susceptibility pattern that does not fit the named organism is a reason to purify and identify again.4
Competency assessment
Training teaches the procedure. Competency assessment shows the person performs it correctly. For moderate- and high-complexity testing, each test's assessment covers six procedures:5
- Direct observation of routine testing.
- Monitoring of result recording and reporting.
- Review of worksheets, QC, proficiency testing and maintenance records.
- Direct observation of instrument maintenance and function checks.
- Testing of previously analyzed, blind or proficiency testing samples.
- Assessment of problem solving.
All six are documented every 6 months in the first year of testing and yearly after that. A new analyzer requires training and documented competency before the person reports patient results.5
Follow the bench demonstration
Sources for this step
References
- Gulati G, Uppal G, Gong J. Unreliable automated complete blood count results: causes, recognition, and resolution. Ann Lab Med. 2022;42(5):515-530. doi:10.3343/alm.2022.42.5.515
- Clinical and Laboratory Standards Institute. One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test. 3rd ed. CLSI standard H47. Clinical and Laboratory Standards Institute; 2023. Accessed September 26, 2026.
- Bazydlo LAL, Marin MJ, Merrill AE, Man LM, Oladipo OO, Harris NS. ADLM guidance document on coagulation testing in patients using direct oral anticoagulants. J Appl Lab Med. 2025;10(6):1675-1690. doi:10.1093/jalm/jfaf155
- Patel R. MALDI-TOF MS for the diagnosis of infectious diseases. Clin Chem. 2015;61(1):100-111. doi:10.1373/clinchem.2014.221770
- Centers for Medicare & Medicaid Services. Assessing Personnel Competency. Revised May 2025. Accessed September 26, 2026.
Watch one
A CBC from an outpatient clinic arrived after a cold morning in transit. The analyzer reports:
- RBC count 2.00 × 10⁶/µL, hemoglobin 11.6 g/dL, hematocrit 23.4%
- MCV 117 fL, MCH 58.0 pg, MCHC 49.6 g/dL
- No flag. Her CBC last month showed hemoglobin 11.9 g/dL, MCV 92 fL and MCHC 33.6 g/dL.
What do you do before release?
- Read the MCHC first: 49.6 g/dL is far above the hemoglobin concentration a red cell can contain.
MCHC has a physiologic ceiling, and a value far above it is an artifact until shown otherwise.
- Read the pattern: the RBC count is low and the MCV high, with a hemoglobin close to her usual. Clumped red cells counted as single large events give this pattern.
The pattern of changed values suggests the cause.
- Inspect the tube for visible agglutination and look at a blood film for red cell clumps.
Agglutinates in the tube or on the film confirm the cause.
- Warm the specimen at 37 °C under the laboratory's validated procedure, then rerun it warm.
Warming disperses cold agglutinates so the cells pass the aperture one at a time.
- Check the warm rerun: RBC count 3.78 × 10⁶/µL, MCV 93 fL, hematocrit 35.2%, MCH 30.7 pg, MCHC 33.0 g/dL.
Consistent indices show the artifact has been removed.
Your turn
Use it
Optional for this step.
- A man (MRN 0194306) is switching from apixaban to an unfractionated heparin infusion.
- His last apixaban dose was 8 hours before collection. The heparin infusion started 4 hours before collection.
- A heparin anti-Xa is ordered, and the laboratory's assay is chromogenic and heparin-calibrated.
- The new coagulation analyzer went live this week.
- Sam, the laboratory professional on the bench, transferred last week. His file contains the vendor's course certificate for the new analyzer and no competency assessment.
| Test | Result | Previous | Reference interval | Flag |
|---|---|---|---|---|
| Heparin anti-Xa | 1.38 IU/mL High | 0.30–0.70 IU/mL0.30–0.70 | High | |
| PT | 14.9 s HighYesterday 07:10: 14.6 s | 14.6 sYesterday 07:10 | 11.5–14.5 s11.5–14.5 | High |
| APTT | 52 s HighYesterday 07:10: 33 s | 33 sYesterday 07:10 | 25–35 s25–35 | High |
| Platelet count | 214 × 10³/µLYesterday 07:10: 226 × 10³/µL | 226 × 10³/µLYesterday 07:10 | 135–317 × 10³/µL135–317 |
Specimen: H 6, L 12, I 2. Citrate plasma, correctly filled; drawn from the arm without the infusion.
The anti-Xa result is explained by what the anti-Xa assay measures. A heparin-calibrated chromogenic method measures all factor Xa inhibition, and apixaban was still present. The transition protocol and its comment prevent the result from being read as heparin alone. Sam's certificate records training only. His competency assessment still has to be documented.
Review missed questions
For reference
Sources checked
The rest of this step has a short briefing, a demonstration at the bench, 3 practice problems and a short case.
Free account: keep your progress and get review reminders. Have one? Sign in